Drugs Made In America Acquisition II Statistics
NASDAQ: DMIIFinanceBlank ChecksUSD
10.190.00 (0.00%)
Market open · Delayed 15 min · as of Oct 8, 11:33 AM ET
Drugs Made In America Acquisition II by the numbers
Drugs Made In America Acquisition II has a market capitalization of $649.1 million based on 63.70M shares outstanding. Its trailing P/E ratio is 34.0. The stock trades 0.4% above its 50-day average and 1.5% above its 200-day average.
Average daily trading volume is 54.52K shares, or about $555,610 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
DMII valuation vs. peer median
| Metric | DMII | Peer median | Difference |
|---|---|---|---|
| Market cap | $649.10M | $543.46M | +19% |
| Avg. volume | 54.52K | 68.10K | -20% |
Peer median across 8 companies: CCXI, CXII, CEPF, XRPN, NWAX, MLAA, BRTM, CRAN.
Valuation
- Market cap
- $649.10M
- P/E (TTM)
- 33.97
- EPS (TTM)
- $0.30
- Shares outstanding
- 63.70M
Price and trading
- Previous close
- 10.19
- Open
- 10.19
- Day range
- 10.19 – 10.19
- 52-week range
- 9.86 – 10.33
- Beta
- —
- Volume
- 250.01K
- Average volume
- 54.52K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 649.10M
- Pe
- 33.97
- Eps
- 0.30
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 10.33
- Week52 Low
- 9.86
- Avg Volume
- 54,525.00
- Shares Outstanding
- 63.70M
- Ma50
- 10.15
- Ma200
- 10.04
- Pct From52w High
- -1.36%
- Pct From52w Low
- 3.35%